Pascal Bamford
Chief Clinical Officer · Akoya Biosciences, Inc.
Individual
- 2024
- Jul 8, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Pascal Bamford's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- TCO GROUP HOLDINGS, L.P. - $92.50M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $92.50M in INNV purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M in KROS purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pascal Bamford?
Pascal Bamford is a corporate insider, tracked as Chief Clinical Officer of Akoya Biosciences, Inc. (AKYA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Pascal Bamford last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2025, one of 2 filings going back to 2024.
